1. Home
  2. BDSX vs GRF Comparison

BDSX vs GRF Comparison

Compare BDSX & GRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • GRF
  • Stock Information
  • Founded
  • BDSX 2005
  • GRF 1989
  • Country
  • BDSX United States
  • GRF United States
  • Employees
  • BDSX N/A
  • GRF N/A
  • Industry
  • BDSX Precision Instruments
  • GRF Finance/Investors Services
  • Sector
  • BDSX Health Care
  • GRF Finance
  • Exchange
  • BDSX Nasdaq
  • GRF Nasdaq
  • Market Cap
  • BDSX 53.2M
  • GRF 42.6M
  • IPO Year
  • BDSX 2020
  • GRF N/A
  • Fundamental
  • Price
  • BDSX $0.43
  • GRF $10.52
  • Analyst Decision
  • BDSX Strong Buy
  • GRF
  • Analyst Count
  • BDSX 5
  • GRF 0
  • Target Price
  • BDSX $1.75
  • GRF N/A
  • AVG Volume (30 Days)
  • BDSX 4.2M
  • GRF 3.0K
  • Earning Date
  • BDSX 10-31-2025
  • GRF 01-01-0001
  • Dividend Yield
  • BDSX N/A
  • GRF 3.70%
  • EPS Growth
  • BDSX N/A
  • GRF N/A
  • EPS
  • BDSX N/A
  • GRF 1.16
  • Revenue
  • BDSX $76,556,000.00
  • GRF N/A
  • Revenue This Year
  • BDSX $18.80
  • GRF N/A
  • Revenue Next Year
  • BDSX $27.76
  • GRF N/A
  • P/E Ratio
  • BDSX N/A
  • GRF $8.15
  • Revenue Growth
  • BDSX 25.70
  • GRF N/A
  • 52 Week Low
  • BDSX $0.17
  • GRF $7.93
  • 52 Week High
  • BDSX $1.88
  • GRF $10.19
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 52.94
  • GRF 53.41
  • Support Level
  • BDSX $0.41
  • GRF $10.50
  • Resistance Level
  • BDSX $0.54
  • GRF $10.87
  • Average True Range (ATR)
  • BDSX 0.04
  • GRF 0.21
  • MACD
  • BDSX -0.00
  • GRF 0.00
  • Stochastic Oscillator
  • BDSX 30.90
  • GRF 55.34

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About GRF Eagle Capital Growth Fund Inc.

Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock by giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.

Share on Social Networks: